Ready to Quit Smoking?
We’re here to help!
Call 941-917-5864 (LUNG) for information and resources on our free smoking cessation programs.
Lung Cancer Screening
Lung cancer is the leading cause of cancer deaths. It can be difficult to detect in its early stages, oftentimes because patients don’t have any symptoms until the tumor has advanced to a late stage of disease. When diagnosed early, lung cancer is highly treatable.
Sarasota Memorial’s Lung Cancer Screening Program uses low-dose computed tomographic screening exams to identify lung cancer at its most treatable stage, before symptoms begin. Studies have shown that an annual low-dose computed tomographic (LDCT) screening is an effective method for catching lung cancer early. LDCT takes a series of detailed pictures capable of detecting many lung diseases and abnormalities, using up to 90 percent less radiation than a normal CT scan.
Medical Director Dr. Joseph Seaman, a critical care pulmonologist, oversees the Sarasota Memorial Lung Cancer Screening Program. Amie Miller, ARNP, is the Lung Cancer Screening Program coordinator. All cases are reviewed with a multidisciplinary team of physicians who specialize in treating pulmonary nodules to identify and coordinate appropriate follow-up care, when needed. Screening patients also receive ongoing education and support.
For more information on LDCT screening and to find out whether it's right for you, call 941-917-5864 (LUNG) or email firstname.lastname@example.org.
Is Lung Cancer Screening Right for You?
Those at high risk for developing lung cancer should consider the simple and painless LDCT screening, particularly if they:
- Are ages 55 to 77.
- Are a current smoker or former smoker who quit within the last 15 years.
- Have a history of at least 30 years of smoking an average of one pack per day.
- Lung cancer screening is covered by Medicare and most major insurance carriers for those who meet eligibility criteria.
Click here to learn more about lung cancer risk factors and lung cancer screening from Dr. Seaman and Paul Chomiak, MD, SMH's director of Thoracic Surgical Oncology.
Accreditations & Honors